|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3119808 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15714116.9 |
| Date of filing the European patent application | 2015-03-18 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation | 2019-10-10 |
| (86) | Number | PCT/US2015/021322 |
| Date | 2015-03-18 |
| (87) | Number | WO 2015/143079 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 201461955663 P | 2014-03-19 | US | |
| 201461981641 P | 2014-04-18 | US | |
| 201462007385 P | 2014-06-03 | US | |
| 201462033460 P | 2014-08-05 | US |
| (72) |
DAVIS, Samuel, US
SMITH, Eric, US
VARGHESE, Bindu, US
KIRSHNER, Jessica R., US
THURSTON, Gavin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnų kompozicijos vėžio gydymui |
| ANTIBODY COMPOSITIONS FOR TUMOR TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 12 | 289.00 EUR |
| 2027-03-18 |